One multicenter retrospective report underscored this possibility following the treatment of EGFR-mutated NSCLC BM with either SRS followed by EGFR-TKI, WBRT followed by EGFR-TKI, or EGFR-TKI followed by SRS or WBRT [43]. Here, EGFR is linked to non-small cell lung carcinoma.